Diaphorina citri psyllid: psy3862


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-
MFQKFLTAMAQKIINDIKLDFKDVMLRPKRSTLKSRSEVDITRTFTFRNSGKTYQGVPIIAANMDTVGTFEMAKHLAKHGLFTTIHKYYTLEEWKAFAVQNPDVIKHVAVSSGISAKDLAGLKEILAALPEIEYICLDVANGYTQTFVDFVRRIREMYPKHVIIAGNVVTGEMVEELILSGADVIKVGIGPGSVCTTRLKNKTSDFFLIQFYSCIPQAGNVVTGEMVEELILSGADVIKVGIGPGSVCTTRLKTGVGYPQFSAVLECADAAHGLGGHIISFLTAMAQKIINDIKLDFKDVMLRPKRSTLKSRSEVDITRTFTFRNSGKTYQGVPIIAANMDTVGTFEMAKHLAKHGLFTTIHKYYTLEEWKAFAVQNPDVIKHVADGGCTSPGDVAKAMGAGADFVMLGGMFAGHDQSGGELTNIEYMFFPLVGDMNSYLGGVVDGGCTSPGDVAKAMGAGADFVMLGGMFAGHDQSGGELIEKDGKKVKLFYGMSSTTAMDKHAGGVAEYRAAEGKTVQVPYRGDVNDTVQDILGGLRSACTYVGASKLKELPRRATFIRCTAQLNNVNDTVQDILGGLRSACTYVGASKLKELPRRATFIRCTAQLNNVAAEGKTVQVPYRGDVNDTVQDILGGLRSACTYVGASKLKELPRRATFIRCTAQLNNMYFI
cHHHHcccHHHHHHccccccccccccccccCECccccccCEEEEEccccccccccccCEECccccccccHHHHHHHHHcccEEEEEEEccHHHHHHHHHcccccccEEEEEEcccccHHHHHHHHHHHcccccEEEEEccccccHHHHHHHHHHHHHccccEEEEcccccHHHHHHHHHccccEEEEccccccCEEEEEEcccccEEEEEccccccccccccHHHHHHHHHHccccEEEEccccccccEEEEEccccccEEEHHHHHHHHHHHccccEEEccHHHHHHHHHcccccccccEEccccccccccccccEEEEECcccccccccccEEEEEcccccccHHHHHHHHHcccEEEEEcccHHHHHHHHHHHcccccccccccccccHHHHHHHHHccccEEEEcEECccEEEEcCEEEEEEEEEccccccccccccEEccccccccHHHHHHHHccccEEEEcccccccccccccEEEEccEEEEEEEEccHHHHHHHHccccccccccccCEEECcccccHHHHHHHHHcccccccccccccccccccccccEEEEccccccccccccccccccccccEEEcccccccccccccccccccccccccccccEEECcccccHHHHHHHHHHcccccccccccccccccccccEEEEEcccccccccc
*FQKFLTAMAQKIINDIKLDFKDVMLRPKRSTLKSRSEVDITRTFTFRNSGKTYQGVPIIAANMDTVGTFEMAKHLAKHGLFTTIHKYYTLEEWKAFAVQNPDVIKHVAVSSGISAKDLAGLKEILAALPEIEYICLDVANGYTQTFVDFVRRIREMYPKHVIIAGNVVTGEMVEELILSGADVIKVGIGPGSVCTTRLKNKTSDFFLIQFYSCIPQAGNVVTGEMVEELILSGADVIKVGIGPGSVCTTRLKTGVGYPQFSAVLECADAAHGLGGHIISFLTAMAQKIINDIKLDFKDVMLRPKRSTLKSRSEVDITRTFTFRNSGKTYQGVPIIAANMDTVGTFEMAKHLAKHGLFTTIHKYYTLEEWKAFAVQNPDVIKHVADGGCTSPGDVAKAMGAGADFVMLGGMFAGHDQSGGELTNIEYMFFPLVGDMNSYLGGVVDGGCTSPGDVAKAMGAGADFVMLGGMFAGHDQSGGELIEKDGKKVKLFYGMSSTTAMDKHAGGVAEYRAAEGKTVQVPYRGDVNDTVQDILGGLRSACTYVGASKLKELPRRATFIRCTAQLNNVNDTVQDILGGLRSACTYVGASKLKELPRRATFIRCTAQLNNVAAEGKTVQVPYRGDVNDTVQDILGGLRSACTYVGASKLKELPRRATFIRCTAQLNNMYFI
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MFQKFLTAMAQKIINDIKLDFKDVMLRPKRSTLKSRSEVDITRTFTFRNSGKTYQGVPIIAANMDTVGTFEMAKHLAKHGLFTTIHKYYTLEEWKAFAVQNPDVIKHVAVSSGISAKDLAGLKEILAALPEIEYICLDVANGYTQTFVDFVRRIREMYPKHVIIAGNVVTGEMVEELILSGADVIKVGIGPGSVCTTRLKNKTSDFFLIQFYSCIPQAGNVVTGEMVEELILSGADVIKVGIGPGSVCTTRLKTGVGYPQFSAVLECADAAHGLGGHIISFLTAMAQKIINDIKLDFKDVMLRPKRSTLKSRSEVDITRTFTFRNSGKTYQGVPIIAANMDTVGTFEMAKHLAKHGLFTTIHKYYTLEEWKAFAVQNPDVIKHVADGGCTSPGDVAKAMGAGADFVMLGGMFAGHDQSGGELTNIEYMFFPLVGDMNSYLGGVVDGGCTSPGDVAKAMGAGADFVMLGGMFAGHDQSGGELIEKDGKKVKLFYGMSSTTAMDKHAGGVAEYRAAEGKTVQVPYRGDVNDTVQDILGGLRSACTYVGASKLKELPRRATFIRCTAQLNNVNDTVQDILGGLRSACTYVGASKLKELPRRATFIRCTAQLNNVAAEGKTVQVPYRGDVNDTVQDILGGLRSACTYVGASKLKELPRRATFIRCTAQLNNMYFI

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
GMP reductase Catalyzes the irreversible NADPH-dependent deamination of GMP to IMP. It functions in the conversion of nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and in maintaining the intracellular balance of A and G nucleotides.confidentA7FM52
GMP reductase Catalyzes the irreversible NADPH-dependent deamination of GMP to IMP. It functions in the conversion of nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and in maintaining the intracellular balance of A and G nucleotides.confidentQ8ZBI2
GMP reductase Catalyzes the irreversible NADPH-dependent deamination of GMP to IMP. It functions in the conversion of nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and in maintaining the intracellular balance of A and G nucleotides.confidentB4SU63

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0055114 [BP]oxidation-reduction processprobableGO:0044710, GO:0008150, GO:0008152
GO:0016491 [MF]oxidoreductase activityprobableGO:0003824, GO:0003674
GO:0042802 [MF]identical protein bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0015951 [BP]purine ribonucleotide interconversionprobableGO:0044237, GO:0015950, GO:0006807, GO:0044281, GO:0072521, GO:0009259, GO:1901360, GO:0006139, GO:0044710, GO:0071704, GO:0009987, GO:0006725, GO:0009150, GO:0009117, GO:0008152, GO:0015949, GO:0055086, GO:0046483, GO:0044238, GO:1901564, GO:1901135, GO:0034641, GO:0019693, GO:0006163, GO:0006796, GO:0006793, GO:0019637, GO:0008150, GO:0006753

Prediction of Enzyme Commission Number ?

EC Number ?Description ?Confidence Level ?
1.-.-.-Oxidoreductases.probable
1.7.-.-Acting on other nitrogenous compounds as donors.probable
1.7.1.-16-alpha-hydroxysteroid dehydrogenase.probable
1.7.1.7Transferred entry: 1.7.1.7.probable

Spatial Structural Prediction

Structural Models Based on Templates

Template: 3USB, chain A
Confidence level:very confident
Coverage over the Query: 10-274,332-337,445-473,542-559,576-585,620-664
View the alignment between query and template
View the model in PyMOL
Template: 1ZFJ, chain A
Confidence level:very confident
Coverage over the Query: 16-273,331-337,445-502,609-660
View the alignment between query and template
View the model in PyMOL
Template: 3USB, chain A
Confidence level:very confident
Coverage over the Query: 290-532
View the alignment between query and template
View the model in PyMOL
Template: 1ME8, chain A
Confidence level:very confident
Coverage over the Query: 159-274,323-337,445-503,515-565
View the alignment between query and template
View the model in PyMOL
Template: 1PII, chain A
Confidence level:probable
Coverage over the Query: 121-282,302-423,435-468
View the alignment between query and template
View the model in PyMOL